Cargando…

Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy

[Image: see text] The discovery of new light-triggered prodrugs based on ruthenium (II) complexes is a promising approach for photoactivated chemotherapy (PACT). The light-mediated activation of “strained” Ru(II) polypyridyl complexes resulted in ligand release and produced a ligand-deficient metal...

Descripción completa

Detalles Bibliográficos
Autores principales: Havrylyuk, Dmytro, Heidary, David K., Sun, Yang, Parkin, Sean, Glazer, Edith C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408248/
https://www.ncbi.nlm.nih.gov/pubmed/32775891
http://dx.doi.org/10.1021/acsomega.0c02079
_version_ 1783567794025005056
author Havrylyuk, Dmytro
Heidary, David K.
Sun, Yang
Parkin, Sean
Glazer, Edith C.
author_facet Havrylyuk, Dmytro
Heidary, David K.
Sun, Yang
Parkin, Sean
Glazer, Edith C.
author_sort Havrylyuk, Dmytro
collection PubMed
description [Image: see text] The discovery of new light-triggered prodrugs based on ruthenium (II) complexes is a promising approach for photoactivated chemotherapy (PACT). The light-mediated activation of “strained” Ru(II) polypyridyl complexes resulted in ligand release and produced a ligand-deficient metal center capable of forming covalent adducts with biomolecules such as DNA. Based on the strategy of exploiting structural distortion to activate photochemistry, biologically active small molecules were coordinated to a Ru(II) scaffold to create light-triggered dual-action agents. Thirteen new Ru(II) complexes with pyridyl-pyrazol(in)e ligands were synthesized, and their photochemical reactivity and anticancer properties were investigated. Isomeric bidentate ligands were investigated, where “regular” ligands (where the coordinated nitrogens in the heterocycles are linked by C–C atoms) were compared to “inverse” isomers (where the coordinated nitrogens in the heterocycles are linked by C–N atoms). Coordination of the regular 3-(pyrid-2-yl)-pyrazol(in)es to a Ru(II) bis-dimethylphenanthroline scaffold yielded photoresponsive compounds with promising photochemical and biological properties, in contrast to the inverse 1-(pyrid-2-yl)-pyrazolines. The introduction of a phenyl ring to the 1N-pyrazoline cycle increased the distortion in complexes and improved ligand release upon light irradiation (470 nm) up to 5-fold in aqueous media. Compounds 1–8, containing pyridyl-pyrazol(in)e ligands, were at least 20–80-fold more potent than the parent pyridyl-pyrazol(in)es, and exhibited biological activity in the dark, with half-maximal inhibitory concentration (IC(50)) values ranging from 0.2 to 7.6 μM in the HL60 cell line, with complete growth inhibition upon light irradiation. The diversification of coligands and introduction of a carboxylic acid into the Ru(II) complex resulted in compounds 9–12, with up to 146-fold improved phototoxicity indices compared with complexes 1–8.
format Online
Article
Text
id pubmed-7408248
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-74082482020-08-07 Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy Havrylyuk, Dmytro Heidary, David K. Sun, Yang Parkin, Sean Glazer, Edith C. ACS Omega [Image: see text] The discovery of new light-triggered prodrugs based on ruthenium (II) complexes is a promising approach for photoactivated chemotherapy (PACT). The light-mediated activation of “strained” Ru(II) polypyridyl complexes resulted in ligand release and produced a ligand-deficient metal center capable of forming covalent adducts with biomolecules such as DNA. Based on the strategy of exploiting structural distortion to activate photochemistry, biologically active small molecules were coordinated to a Ru(II) scaffold to create light-triggered dual-action agents. Thirteen new Ru(II) complexes with pyridyl-pyrazol(in)e ligands were synthesized, and their photochemical reactivity and anticancer properties were investigated. Isomeric bidentate ligands were investigated, where “regular” ligands (where the coordinated nitrogens in the heterocycles are linked by C–C atoms) were compared to “inverse” isomers (where the coordinated nitrogens in the heterocycles are linked by C–N atoms). Coordination of the regular 3-(pyrid-2-yl)-pyrazol(in)es to a Ru(II) bis-dimethylphenanthroline scaffold yielded photoresponsive compounds with promising photochemical and biological properties, in contrast to the inverse 1-(pyrid-2-yl)-pyrazolines. The introduction of a phenyl ring to the 1N-pyrazoline cycle increased the distortion in complexes and improved ligand release upon light irradiation (470 nm) up to 5-fold in aqueous media. Compounds 1–8, containing pyridyl-pyrazol(in)e ligands, were at least 20–80-fold more potent than the parent pyridyl-pyrazol(in)es, and exhibited biological activity in the dark, with half-maximal inhibitory concentration (IC(50)) values ranging from 0.2 to 7.6 μM in the HL60 cell line, with complete growth inhibition upon light irradiation. The diversification of coligands and introduction of a carboxylic acid into the Ru(II) complex resulted in compounds 9–12, with up to 146-fold improved phototoxicity indices compared with complexes 1–8. American Chemical Society 2020-07-23 /pmc/articles/PMC7408248/ /pubmed/32775891 http://dx.doi.org/10.1021/acsomega.0c02079 Text en Copyright © 2020 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Havrylyuk, Dmytro
Heidary, David K.
Sun, Yang
Parkin, Sean
Glazer, Edith C.
Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy
title Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy
title_full Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy
title_fullStr Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy
title_full_unstemmed Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy
title_short Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy
title_sort photochemical and photobiological properties of pyridyl-pyrazol(in)e-based ruthenium(ii) complexes with sub-micromolar cytotoxicity for phototherapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408248/
https://www.ncbi.nlm.nih.gov/pubmed/32775891
http://dx.doi.org/10.1021/acsomega.0c02079
work_keys_str_mv AT havrylyukdmytro photochemicalandphotobiologicalpropertiesofpyridylpyrazolinebasedrutheniumiicomplexeswithsubmicromolarcytotoxicityforphototherapy
AT heidarydavidk photochemicalandphotobiologicalpropertiesofpyridylpyrazolinebasedrutheniumiicomplexeswithsubmicromolarcytotoxicityforphototherapy
AT sunyang photochemicalandphotobiologicalpropertiesofpyridylpyrazolinebasedrutheniumiicomplexeswithsubmicromolarcytotoxicityforphototherapy
AT parkinsean photochemicalandphotobiologicalpropertiesofpyridylpyrazolinebasedrutheniumiicomplexeswithsubmicromolarcytotoxicityforphototherapy
AT glazeredithc photochemicalandphotobiologicalpropertiesofpyridylpyrazolinebasedrutheniumiicomplexeswithsubmicromolarcytotoxicityforphototherapy